Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
2-(5-fluoro-pentyl)-2-methyl-malonic-acid (4 trials)
Brain Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms, Second Primary (Phase 2)
Trials (4 total)
Trial APIs (1 total)